RadiaDyne

Radiation Oncology Products

RadiaDyne Receives Clearance for Two Additional FDA Indications for the OARtrac System

"RadiaDyne announces it received notice of additional FDA clearance for two new Indications of Use for their upcoming OARtrac® radiation dose monitoring platform. "


New publication for SBRT Prostate Treatment
Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer

To read this publication please click here

Independent Journal Article Highlighting Advantages of In-Vivo Optical Fibre Based Dosimetry Systems

"With more PSDs set to enter the market focused on in vivo applications, RadiaDyne has the potential for widespread clinical adoption of optical fibre-based dosemeters"

RadiaDyne